Our Unique Technology
PolyActiva is a clinical-stage ophthalmology company that develops unique ocular implants to treat ocular diseases of the eye.
Here is a recap of our unique technology.
PolyActiva completes recruitment in key Phase I glaucoma implant safety study. Six-month treatment period demonstrated.
July 23, Chicago – PolyActiva Pty Ltd, a clinical-stage biotechnology company and leader in ocular drug delivery, has completed patient enrolment for its Phase I clinical trial to study safety and tolerability of its biodegradable, slow-release ocular implant for the treatment of glaucoma…
PolyActiva commences its first Phase I clinical trial
PolyActiva Pty Ltd, a clinical-stage Australian biotechnology company, has recently recruited first patients into its Phase I clinical study designed to show its glaucoma implant is safe and well tolerated…
The Hydrolysis of Diclofenac Esters: Synthetic Prodrug Building blocks for Biodegradable Drug-Polymer Conjugates
J Pharm Sci (2016) 105, 773-785 (Research Article – Pharmaceutical, Drug Delivery and Pharmaceutrical Technology). DOI:10.1002/jps.24665, Published:8 September 2015.